Real-time enrollment status for this metastatic castration resistant prostate cancer (mcrpc) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:48 AM UTC
| NCT Number | NCT07285694 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| Phase | Clinical Trial |
| Target Enrollment | 190 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Arsenal Biosciences, Inc. |
| Last Updated on CT.gov | June 5, 2026 (Jun 5, 2026) |
As of July 13, 2026: Clinical trial NCT07285694 is currently recruiting participants. This clinical trial study for metastatic castration resistant prostate cancer (mcrpc) is actively seeking new participants at 9 locations across the United States. The study is sponsored by Arsenal Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07285694 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07285694 was last updated Jun 5, 2026 (June 5, 2026). HelloStudys verifies this status automatically.